REVVITY, INC Interest Expense Nonoperating
REVVITY, INC (RVTY) reported Interest Expense Nonoperating of $22.99 million for the 3-month period ending 2026-07-05, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-11
- REVVITY, INC interest expense nonoperating for the quarter ending 2026-07-05 was $22.99M, a 0.23% increase year-over-year.
- REVVITY, INC interest expense nonoperating for the quarter ending 2026-04-05 was $24.72M, a 7.64% increase year-over-year.
- REVVITY, INC interest expense nonoperating for the quarter ending 2025-12-28 was $23.51M, a 3.21% increase year-over-year.
- REVVITY, INC interest expense nonoperating for the quarter ending 2025-09-28 was $22.77M, a 6.61% decline year-over-year.
- REVVITY, INC interest expense nonoperating for fiscal 2025 was $92.19M, a 4.25% decline from fiscal 2024.
- REVVITY, INC interest expense nonoperating for fiscal 2024 was $96.28M, a 2.57% decline from fiscal 2023.
- REVVITY, INC interest expense nonoperating for fiscal 2023 was $98.81M, a 4.95% decline from fiscal 2023.
- REVVITY, INC interest expense nonoperating for fiscal 2023 was $103.95M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-07-05 | $22.99M 10-Q · filed 2026-08-11 | $47.71M 10-Q · filed 2026-08-11 | $71.22M derived: sum of 3 quarters · filed 2026-08-11 | $93.99M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-04-05 | $24.72M 10-Q · filed 2026-05-12 | $48.23M derived: sum of 2 quarters · filed 2026-05-12 | $71.00M derived: sum of 3 quarters · filed 2026-05-12 | $93.94M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-28 | $23.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $46.28M derived: sum of 2 quarters · filed 2026-02-24 | $69.22M derived: sum of 3 quarters · filed 2026-08-11 | $92.19M 10-K · filed 2026-02-24 |
| 2025-09-28 | $22.77M 10-Q · filed 2025-11-04 | $45.71M derived: sum of 2 quarters · filed 2026-08-11 | $68.67M 10-Q · filed 2025-11-04 | $91.45M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-29 | $22.94M 10-Q · filed 2026-08-11 | $45.90M 10-Q · filed 2026-08-11 | $68.68M derived: sum of 3 quarters · filed 2026-08-11 | $93.06M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-30 | $22.96M 10-Q · filed 2026-05-12 | $45.74M derived: sum of 2 quarters · filed 2026-05-12 | $70.13M derived: sum of 3 quarters · filed 2026-05-12 | $94.84M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-29 | $22.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $47.16M derived: sum of 2 quarters · filed 2026-02-24 | $71.88M derived: sum of 3 quarters · filed 2026-02-24 | $96.28M 10-K · filed 2026-02-24 |
| 2024-09-29 | $24.38M 10-Q · filed 2025-11-04 | $49.10M derived: sum of 2 quarters · filed 2025-11-04 | $73.50M 10-Q · filed 2025-11-04 | $98.08M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $24.72M 10-Q · filed 2025-08-05 | $49.11M 10-Q · filed 2025-08-05 | $73.70M derived: sum of 3 quarters · filed 2026-02-24 | $99.18M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $24.40M 10-Q · filed 2025-05-06 | $48.98M derived: sum of 2 quarters · filed 2026-02-24 | $74.47M derived: sum of 3 quarters · filed 2026-02-24 | |
| 2023-12-31 | $24.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $50.07M derived: sum of 2 quarters · filed 2026-02-24 | $98.81M 10-K · filed 2026-02-24 | |
| 2023-10-01 | $25.49M 10-Q · filed 2024-11-06 | $74.23M 10-Q · filed 2024-11-06 | ||
| 2023-01-01 | $103.95M 10-K · filed 2025-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |